| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $146.6M | +24.6% |
| Gross Profit | $62.8M | +149.1% |
| R&D Expense | $4.4M | +5.2% |
| SG&A Expense | $42.0M | -9.7% |
| Operating Income | -$17.4M | +77.3% |
| Pre-tax Income | -$17.1M | -146.8% |
| Income Tax | -$14.2M | -313.0% |
| Net Income | -$9.4M | -123.0% |
| EPS (Basic) | -$0.02 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $791.8M | -7.8% |
| Short-term Investments | $40.0M | — |
| Accounts Receivable | $34.1M | +120.5% |
| Inventory | $46.8M | +41.0% |
| Current Assets | $944.1M | +0.9% |
| Total Assets | $1.20B | +2.6% |
| Current Liabilities | $48.2M | -3.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $25.9M | +37.3% |
| Capital Expenditures | $25.7M | +107.2% |
| Investing Cash Flow | -$76.6M | -143.7% |
| Financing Cash Flow | -$19.9M | -1517.0% |
| Free Cash Flow | $149K | -97.7% |
| -118.2% |
| EPS (Diluted) | -$0.02 | -118.2% |
| Total Liabilities |
| $54.2M |
| -2.1% |
| Stockholders' Equity | $1.09B | +2.8% |